45 results on '"Hamilton, Chad"'
Search Results
2. Do U.S. Screening Guidelines Contribute to Higher Stage and Worse Survival in our Youngest and Oldest Cervical Cancer Patients? (019)
3. Tools for survivorship care planning in uterine serous carcinoma (497)
4. Conditional estimates for uterine serous cancer: Tools for survivorship counseling and planning
5. Survival advantage for chemoradiation compared with monotherapy in stage IVB cervical cancer: a propensity score balanced observational investigation
6. Impact of stage and grade on conditional survival in 173,211 women with endometrioid endometrial carcinoma
7. The impact of age and stage on the competing risk of cancer-related and non-cancer death in low- or high-grade endometrioid endometrial carcinoma and uterine serous carcinoma
8. Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations, part II
9. Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations
10. Minority participation in phase 1 gynecologic oncology clinical trials: Three decades of inequity
11. Racial disparities in uterine and ovarian carcinosarcoma: A population-based analysis of treatment and survival
12. Impact of adjuvant treatment and prognostic factors in stage I uterine leiomyosarcoma patients treated in Commission on Cancer®-accredited facilities
13. Prospective follow-up of quality of life for participants undergoing risk-reducing salpingo-oophorectomy or ovarian cancer screening in GOG-0199: An NRG Oncology/GOG study
14. Biomarker panel for early detection of endometrial cancer in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial
15. Assessing recurrence risk following intraperitoneal chemotherapy for ovarian cancer: A day late and a dollar short?
16. Correlation between Surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study
17. Impact of age at diagnosis on racial disparities in endometrial cancer patients
18. Racial disparities in molecular subtypes of endometrial cancer
19. Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study
20. Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: a NRG/Gynecologic Oncology Group study
21. Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study
22. Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis
23. Progestins inhibit calcitriol-induced CYP24A1 and synergistically inhibit ovarian cancer cell viability: An opportunity for chemoprevention
24. Nestin: A biomarker of aggressive uterine cancers
25. Identification and functional characterization of a novel bipartite nuclear localization sequence in ARID1A
26. Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells
27. MicroRNAs in endometrial cancers from black and white patients
28. Survival advantage of marriage in uterine cancer patients contrasts poor outcome for widows: A Surveillance, Epidemiology and End Results study
29. Pyocolpos presenting as a large pelvic mass after total colpocleisis
30. Upper abdominal procedures in advanced stage ovarian or primary peritoneal carcinoma patients with minimal or no gross residual disease: An analysis of Gynecologic Oncology Group (GOG) 182
31. Transcript expression in endometrial cancers from Black and White patients
32. Factors associated with publication of plenary presentations at the Society of Gynecologic Oncologists annual meeting
33. Takotsubo cardiomyopathy following laparoscopic port placement in a patient with ovarian cancer
34. Should stage IIIC ovarian cancer be further stratified by intraperitoneal vs. retroperitoneal only disease?: A Gynecologic Oncology Group study
35. Re: Implications of upper abdominal disease in advanced ovarian cancer after surgical cytoreduction and relation with tumor biology
36. The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: A gynecologic oncology group study
37. Intraperitoneal bevacizumab for the palliation of malignant ascites in refractory ovarian cancer
38. Benign Disorders of the Ovary
39. A novel technique for the enrichment of primary ovarian cancer cells
40. Acute postoperative thrombotic thrombocytopenic purpura following hysterectomy and lymphadenectomy for endometrial cancer
41. The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of patients with advanced stage uterine papillary serous carcinoma
42. Outcomes of women with metachronous breast and ovarian carcinomas
43. Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinoma
44. Effect of excisional therapy and highly active antiretroviral therapy on cervical intraepithelial neoplasia in women infected with human immunodeficiency virus
45. Femoral Artery Occlusion Following Pelvic Cancer Surgery
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.